Markel Group Inc. Purchases 13,750 Shares of CME Group Inc. $CME

Posted by Stanley Muller on May 23rd, 2026

Markel Group Inc. lifted its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 43.0% during the fourth quarter, Holdings Channel reports. The firm owned 45,750 shares of the financial services provider’s stock after acquiring an additional 13,750 shares during the period. Markel Group Inc.’s holdings in CME Group were worth $12,493,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in shares of CME Group by 1.7% during the fourth quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock valued at $9,802,366,000 after purchasing an additional 588,509 shares in the last quarter. Ameriprise Financial Inc. raised its position in CME Group by 2.8% in the third quarter. Ameriprise Financial Inc. now owns 4,812,914 shares of the financial services provider’s stock worth $1,300,450,000 after acquiring an additional 130,848 shares during the period. Sanders Capital LLC bought a new stake in CME Group in the third quarter worth about $1,006,932,000. Franklin Resources Inc. raised its position in CME Group by 0.6% in the third quarter. Franklin Resources Inc. now owns 3,381,133 shares of the financial services provider’s stock worth $913,548,000 after acquiring an additional 20,213 shares during the period. Finally, Invesco Ltd. raised its position in CME Group by 23.0% in the third quarter. Invesco Ltd. now owns 2,830,323 shares of the financial services provider’s stock worth $764,725,000 after acquiring an additional 528,358 shares during the period. 87.75% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have commented on CME shares. Barclays lowered their price objective on shares of CME Group from $343.00 to $316.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 23rd. TD Cowen lowered their price objective on shares of CME Group from $340.00 to $323.00 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Erste Group Bank raised shares of CME Group from a “hold” rating to a “strong-buy” rating in a research report on Thursday, March 5th. Morgan Stanley lowered their price objective on shares of CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a research report on Thursday, April 23rd. Finally, Keefe, Bruyette & Woods started coverage on shares of CME Group in a research report on Wednesday, April 8th. They issued a “market perform” rating and a $305.00 price objective on the stock. Two analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $305.29.

Read Our Latest Research Report on CME

Insider Buying and Selling at CME Group

In other news, General Counsel Jonathan L. Marcus sold 3,291 shares of the business’s stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $333.37, for a total value of $1,097,120.67. Following the sale, the general counsel owned 7,192 shares of the company’s stock, valued at $2,397,597.04. The trade was a 31.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the transaction, the insider directly owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 48,244 shares of company stock worth $14,598,037. 0.30% of the stock is currently owned by company insiders.

CME Group Stock Performance

NASDAQ CME opened at $291.23 on Friday. The company’s 50 day moving average is $296.38 and its 200-day moving average is $289.12. CME Group Inc. has a 12-month low of $257.17 and a 12-month high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market cap of $105.53 billion, a P/E ratio of 24.85, a price-to-earnings-growth ratio of 3.50 and a beta of 0.23.

CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.11 by $0.25. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same quarter in the previous year, the firm posted $2.80 earnings per share. The company’s quarterly revenue was up 14.5% compared to the same quarter last year. Sell-side analysts predict that CME Group Inc. will post 12.26 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be given a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.8%. CME Group’s payout ratio is 44.37%.

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.